4/A//SEC Filing
Horizon Pharma plc 4/A
Accession 0001209191-17-031416
CIK 0001492426operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:21 PM ET
Size
8.2 KB
Accession
0001209191-17-031416
Insider Transaction Report
Form 4/AAmended
Nohria Virinder
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-05-03−13,953→ 0 total→ Ordinary shares (13,953 underlying) - Exercise/Conversion
Ordinary Shares
2017-05-03+13,953→ 19,211 total(indirect: By Trust)
Holdings
- 189,836
Ordinary Shares
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4/A
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 7:21 PM ET
- Size
- 8.2 KB